The J.P. Morgan Healthcare Conference is a time for industry to reflect, assess, and forecast, and this year’s 37th annual conference was no exception.
Below is a summary of the most important news from JPM 2019, as selected by BulletinHealthcare’s expert analysts.
Analysts Offer Thoughts On BMS-Celgene Merger: MedCity News
Pfizer Staying In Neuroscience By Funding Startups: Business Insider
J&J Expecting Big Things In Immunology From Tremfya: Fierce Pharma Marketing
Sage Preparing To Launch Two Postpartum Depression Drugs: Boston Business Journal
Other News of Note
Analysis: Executives Come Away From JPM19 With “Cautious Optimism:” Fierce Pharma
Biotech A Safe Bet, More Deals On the Horizon: Financial Times
Analysis Examines NASH Insights From JPM19: BioPharma Dive
For more insights like these, follow us on LinkedIn and watch this space!